Literature DB >> 7710645

Influence of demographic variables on the Dementia Rating Scale.

A M Paolo1, A I Tröster, S L Glatt, J P Hubble, W C Koller.   

Abstract

Demographic characteristics influence many cognitive assessment tools. We evaluated the impact of age, education, and gender on the Dementia Rating Scale (DRS) in a sample of 212 normal people. Separate regression analyses revealed that age was the most potent demographic factor, whereas education and gender had little impact. However, the amount of variance accounted for by age was small (less than 20%). Clinical utility of age-adjusted DRS total score cut-offs was investigated in samples of Alzheimer's and Parkinson's disease patients. Hit rate analysis revealed greater sensitivity for a single cut-off value than age-corrected cut-off scores. Overall, these findings revealed the lack of a clinically meaningful relationship between demographic characteristics and DRS scores, suggesting that age, education, and gender can be ignored for interpretative purposes based on cut-off scores.

Entities:  

Mesh:

Year:  1995        PMID: 7710645

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  3 in total

1.  Predictors of performance on the MMSE and the DRS-2 among American Indian elders.

Authors:  Lori L Jervis; Alexandra Fickenscher; Janette Beals; C Munro Cullum; Douglas K Novins; Spero M Manson; David B Arciniegas
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

2.  Affective behavioural disturbances in Alzheimer's disease and ischaemic vascular disease.

Authors:  R Hargrave; L C Geck; B Reed; D Mungas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-01       Impact factor: 10.154

3.  Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale.

Authors:  Erin E Morgan; Steven Paul Woods; J Cobb Scott; Meredith Childers; Jennifer Marquie Beck; Ronald J Ellis; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2007-04-20       Impact factor: 2.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.